PubRank

Philip G Janicak

Author PubWeight™ 26.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007 5.59
2 Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety 2012 2.23
3 A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2004 1.26
4 Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disord 2010 1.15
5 Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 2004 1.02
6 Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry 2008 1.01
7 Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry 2011 0.95
8 Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol 2003 0.94
9 An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia. Psychiatry Res 2009 0.91
10 Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 2002 0.90
11 A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. J Child Adolesc Psychopharmacol 2006 0.87
12 Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 2005 0.86
13 A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry 2014 0.86
14 Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients. Drugs Aging 2012 0.82
15 Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Anal Bioanal Chem 2003 0.81
16 Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment. Psychopharmacology (Berl) 2003 0.80
17 Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania. J Child Adolesc Psychopharmacol 2002 0.79
18 The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia. Essent Psychopharmacol 2005 0.79
19 Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial". Biol Psychiatry 2010 0.78
20 The borderland of autonomy: medical-legal criteria for capacity to consent. J Psychiatry Law 1980 0.77
21 Aripiprazole for late-life schizophrenia. Clin Interv Aging 2010 0.76
22 Vagus nerve stimulation for severe depression. J Psychosoc Nurs Ment Health Serv 2007 0.76
23 Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression. Am J Psychiatry 2007 0.75
24 Deposition of 7-aminoclonazepam and clonazepam in hair following a single dose of Klonopin. J Anal Toxicol 2002 0.75
25 The CATIE study and its implications for antipsychotic drug use. Essent Psychopharmacol 2006 0.75
26 Iloperidone for schizophrenia. Expert Opin Pharmacother 2010 0.75
27 An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MD. CNS Spectr 2008 0.75
28 The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault. J Forensic Sci 2002 0.75